AzTrials
AzTrials

Forefoot AdductusMediopied-PCNCT05662046

Deformity of the Forefoot in Children With Unilateral Cerebral Palsy

An observational study of Forefoot Adductus and Cerebral Palsy, run by University Hospital, Brest at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Midfoot and backfoot deformities are well described in children with Cerebral palsy. However, data regarding forefoot deformities in Cerebral palsy remain scarce in a population were foot deformities are the most frequent musculo-skeletal deformities. Read more about this study

Who is it for?
Ages 2 to 18 years
Conditions the study is for
Forefoot Adductus, Cerebral Palsy
How many people
52 participants
Where
2 sitesFrance
Study dates
14 Jun 2018to 14 Jun 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Walking child with unilateral Cerebral Palsy who benefit of a 3D Motion Analysis on the motion analysis laboratory in Brest, France, between august 2012 and may 2017.

Who may be able to join

  • Child who benefit a standardised clinical evaluation before a 3D Gait Analysis with forefoot deformity measure
  • Child age less than 18 years old
  • Child with left or right unilateral cerebral palsy
  • Walking child ( GMFCS score I, II or III)
  • In case of several 3D Gait Analysis for the child: the 3D gait analysis was chosen first before any local spasticity treatment with botulinic toxin injection or the 3D gait evaluation the more far from local spastica treatment with botulinic toxin injection was chosen in second .

Who cannot join

  • Hemiplegia due to another etiology
  • History of lower limb or foot surgery before the clinical evaluation
  • Local spasticy treatment with botulinic toxin injection less than 3 months before the clinical evaluation
  • Participation refusal

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Houx

    Brest, 29609

  • PRIGENT

    Concarneau, 29900

Other trials in France

About this study

Midfoot and backfoot deformities are well described in children with Cerebral palsy. However, data regarding forefoot deformities in Cerebral palsy remain scarce in a population were foot deformities are the most frequent musculo-skeletal deformities.

Read the detailed description

Foot deformities are the most frequent musculo-skeletal deformities in children with Cerebral palsy. Pain starts in the foot, especially during gait in Cerebral Palsy Children (GMFCS I and II) and induce gait limitations, balance disorders, wounds, aesthetic disorders and difficulties to support shoes.

Metatarsus Adductus is the most common foot deformity in children with or without disorder, occuring on 1-2/1000 births. In 4 to 14% of the children, evolution is not favorable at 5 years. In that case, the diagnostic of Cerebral palsy have to be considered.

Keywords
Cerebral Palsy, Forefoot Deformity
Medical subject headings
Cerebral Palsy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure of the forefoot deformity prevalence in plegia and non-plegia foot during gait in unilateral cerebral palsy children

    we report in our population the forefoot axis measured by the angle between the heel bisector and the axis between the second and third metatarsal.

    Measured: 1 day

Secondary outcomes (7)
  1. Anthropometric factors (age) associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

    we report the age (years mean, standard deviation) of the patients CP

    Measured: 1 day

  2. Anthropometric factors (sexe) associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

    we report the sexe of the patients (female or male)

    Measured: 1 day

  3. Anthropometric factors (type of cerebral palsy)associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

    we report the plegia side of the patients cerebral palsy : right or left

    Measured: 1 day

  4. functional factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

    we report the GMFCS score of the patients cerebral palsy : GMFCS 1, 2, 3, 4 or 5 (4-5 non ambulant 1-3 ambulant children)

    Measured: 1 day

  5. biomechanical osteoarticular factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

    we report biomechanical osteoarticular factors : hindfoot axis, foot dorsiflexion, footprint, tibial torsion, femoral antetorsion, leg length inequality) , Spasticity of lower limb muscle (Modified Ashworth Scale and Tardieu Scale) and Motricity of lower limb muscle ( Boyd scale and MRC evaluation)

    Measured: 1 day

  6. Spasticity factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

    we report the Spasticity of lower limb muscle (Modified Ashworth Scale and Tardieu Scale)

    Measured: 1 day

  7. Motricity factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

    we report the motricity of lower limb muscle ( Boyd scale and MRC evaluation)

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2022
  2. Study start14 Jun 2018
  3. Primary completion14 Jun 2018
  4. Study completion14 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05662046
Sponsor's protocol ID
Mediopied-PC
Acronym
Mediopied-PC
Status last verified
Dec 2022
First submitted
28 Mar 2019
Last updated
22 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

An observational study of Forefoot Adductus and Cerebral Palsy, run by University Hospital, Brest at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure of the forefoot deformity prevalence in plegia and non-plegia foot during gait in unilateral cerebral palsy children (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in